In this Health Policy Report, the author examines the economics of the pharmaceutical industry. Research-and-development costs, patent laws, and health insurance coverage all influence drug pricing. The author discusses the policy dilemmas resulting from the complex economics of pharmaceutical research and development and reviews potential strategies to control prices.
No takes yet. Share an insight, caveat, or question.
F. M. Scherer (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: